Viking Therapeutics (VKTX) Return on Equity: 2015-2025
Historic Return on Equity for Viking Therapeutics (VKTX) over the last 11 years, with Sep 2025 value amounting to -0.31%.
- Viking Therapeutics' Return on Equity fell 21.00% to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year decrease of 21.00%. This contributed to the annual value of -0.18% for FY2024, which is 17.00% up from last year.
- Per Viking Therapeutics' latest filing, its Return on Equity stood at -0.31% for Q3 2025, which was down 50.61% from -0.21% recorded in Q2 2025.
- Over the past 5 years, Viking Therapeutics' Return on Equity peaked at -0.10% during Q2 2024, and registered a low of -0.52% during Q1 2023.
- Moreover, its 3-year median value for Return on Equity was -0.21% (2025), whereas its average is -0.22%.
- In the last 5 years, Viking Therapeutics' Return on Equity decreased by 22bps in 2023 and then skyrocketed by 37bps in 2024.
- Over the past 5 years, Viking Therapeutics' Return on Equity (Quarterly) stood at -0.26% in 2021, then dropped by 20bps to -0.46% in 2022, then climbed by 22bps to -0.24% in 2023, then increased by 12bps to -0.12% in 2024, then declined by 21bps to -0.31% in 2025.
- Its Return on Equity stands at -0.31% for Q3 2025, versus -0.21% for Q2 2025 and -0.15% for Q1 2025.